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Tuberculous and cryptococcal meningitis (TBM and CM) are the most common causes of opportunistic meningitis in HIV-infected patients. [1] [2] [3] [4] [5] TBM and CM share similar clinical and laboratory features, resulting in delays to diagnosis and poorer outcomes, particularly in settings where confirmatory diagnosis is not possible. [6] Clinical algorithms have been proposed to simplify the diagnosis and treatment of these neurological infections, [6] [7] [8] but a lack of sensitivity and specificity precludes their implementation in clinical practice.
The objective of this study was to compare clinical and laboratory findings of TBM and CM in HIV-infected patients to propose an algorithm to differentiate these diseases.
Methods
We retrospectively analysed data from the clinical records of 108 and 98 HIV-infected patients with a culture-proven diagnosis of TBM or CM, respectively. The patients were admitted between March 1999 and June 2008 at the Emílio Ribas Institute of Infectious Diseases, São Paulo, Brazil. This hospital is a 250-bed tertiary teaching centre and the main referral institution for HIV-infected patients in São Paulo State. HIV infection was diagnosed by ELISA and confirmed by Western blot. We evaluated demographic, clinical, radiological and laboratory information. The study was approved by the ethical and scientific boards of the institution.
Cerebrospinal fluid (CSF) was obtained by lumbar puncture at hospital admission. Pleocytosis was defined as a leukocyte count >5 cells/µL. The normal range of lumbar CSF glucose is >2.22 mmol/L (40 mg/dL) and CSF protein <0.45 g/L (45 mg/dL). Neutrophil pleocytosis was defined as >50% CSF leukocytes.
The comparison between groups (TBM v. CM) was performed using the Mann-Whitney U-test for numeric variables and Yates corrected χ 2 or Fisher's exact test as appropriate for categorical variables. Odds ratio (OR) and 95% confidence interval (CI) were adjusted using a binary logistic regression model (Wald test) and included diagnosis of TBM v. CM as the dependent variable. Covariates and factors associated with TBM (v. CM) in univariate analysis were included to derive a diagnostic index based on clinical, laboratory and radiological findings. A receiver operating characteristics (ROC) curve was derived to calculate the accuracy of the logistic model. An estimation of cut-off for the diagnosis index was made to distinguish between TBM and CM. Statistical significance was defined as p<0.05, and SPSS 20.0 (IBM Corp., USA) software was used for statistical analysis. Tables 2 and 3 show the results of univariate and multivariate modelling to identify variables associated with TBM.
Results
A diagnostic index was derived using a multi variate model as follows: 1.635 × (protein >1.0 g/L) + 1.132 × (Glasgow Coma Scale (GCS) <15) ˗ 1.296 × (nausea and vomiting) + 3.578 × (CSF with polymorphs predominance) + 2.244 × (pleocytosis).
The parameters in parenthesis were coded 1 if present or 0 if absent. We excluded the value of the constant in the calculation of the index. The diagnostic index was a number that varied from ˗1.296 to 8.589, and negative values favoured a diagnosis of CM, while positive values favoured a diagnosis of TBM. The area under the ROC curve was 0.815 (95% CI 0.758 -0.873; p<0.0001). At a cut-off of 1.04, sensitivity was 96.0% and specificity 73.1%. Values >1.04 presented a remarkable fall in the level of sensiti vity -a cut-off of 5.33 presented a specificity of 100% but a sensitivity of 34.7% -while values <1.04, such as ˗0.73, presented higher sensiti vity (100%) but lower specificity (3.2%). Fig. 1 shows the ROC curve of the logistic model.
Discussion
To the best of our knowledge this is the largest study comparing culture-proven CM and TBM in HIV-infected patients. Although some clinical and CSF characteristics appear useful to the discrimination of these two diseases, a diagnostic index could not be derived because of a lack of sensitivity and specificity, similar to that reported in a previous study, [6] which derived an area under the ROC curve very close to ours in spite of the smaller number of patients in the groups. A highly accurate logistic model did not result in an index with a cut-off sufficiently sensitive and specific to distinguish TBM and CM using clinical and laboratory features.
In the current study, CSF protein >1.0 g/L, GCS <15, absence of nausea and vomiting, neutrophil pleocytosis and CSF pleocytosis were independently associated with TBM diagnosis. There are few studies with a hetero geneous design comparing TBM and CM. Similar to our findings, GCS <15, [6] pleocytosis, [6] and neutrophil pleocytosis [9] have been found related to TBM. Fever, [6, 10] neck stiffness, [6] brain CT abnormalities, [10, 11] RESEARCH and extrameningeal disease [10] have been reported more frequently in TBM in other studies than in our study. In these studies, the variables of headache, [11] vomiting, [11] altered sensorium, [11] high opening pressure, [6] low CSF white blood cell count [6] and advanced immunosupression [9, 11] were more frequent in patients with CM. These results indicate that some clinical and laboratory characteristics seem useful in the differential diagnosis of TBM and CM; however, in clinical practice, they do not usually allow for sufficient discrimination between these two diseases.
Culture is the mainstay for diagnosis of TBM and CM, but alternative tests are evolving to provide more rapid and reliable diagnosis. In clinical practice, the India ink microscopy stain is usually available for cryptococcal diagnosis in resource-limited settings. Yet, in referral centres in Africa, India ink has only ~85% sensitivity, [12] similar to the sensitivity in our study. The use of India ink can be particularly problematic for early and/or lowburden infections, with sensitivity only 40% for quantitative cultures <1 000 colonyforming U/mL of CSF. [12] Thus, cryptococcal antigen (CrAg) tests could be necessary in at least 15% of patients with CM and negative India ink microscopy. In people with AIDS who have a negative India ink microscopy, the most common cause of meningitis is Cryptococcus in high-burden regions. [12] Recently, the World Health Organization included the CSF latex CrAg agglutination or lateral flow immunochromatographic assay (LFA) as the preferred diagnostic approach for CM.
In our study, the sensitivity of CSF CrAg latex agglutination was only 82%, lower than usually reported for this test (93 -100%). [13] CSF CrAg LFA (Immuno-Mycologics, USA) has a reported sensitivity of 99.3%, specificity of 99.1%, positive predictive value of 99.5% and negative predictive value of 98.7%. [12] CRAg LFA is a 'dipstick' test that requires only a drop of CSF and is relatively inexpensive, quick and easy to interpret. Unlike traditional latex agglutination, CrAg LFA does not require laboratory infrastructure or coldchain transport. [13] Unfortunately, rapid diagnosis of TBM is more complicated. Detection of AFB in patient samples using Ziehl-Neelsen staining is widely employed for diagnosis of TBM. AFB microscopy is, however, insensitive in TBM, with sensitivity rates of <10 -20%. [14] The sensiti vity of AFB microscopy in our study was only 5%. The sensitivity of smear micro scopy in TBM can be maximised by examination of large-volume CSF samples (>6 mL) using several CSF specimens collected over a few days and prolonged slide examination (≥30 min). [15] However, these criteria are rarely achieved in practice. Recent modifications to the ZiehlNeelsen stain have shown optimistic results, [16] but replication in other sites is required. Over several decades, nucleic acid amplification tests (NAATs) of Mycobacterium tuberculosis have been evaluated for the diagnosis of TBM. A recent systematic review and metaanalysis of commercial NAATs with a CSF of M. tuberculosis culture-positive gold standard found a sensitivity of 64% and a specificity of 98%. [17] Despite suboptimal sensitivity, the rapid turnaround time of NAATs compared with culture enhances their role in the early accurate diagnosis of TBM. However, NAATs 
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are unavailable for most resource-limited laboratories. Yet, the availability of automated NAATs via the GeneXpert system (Cepheid, USA) is increasing, but testing a large volume of centrifuged CSF remains essential.
In terms of the current status of meningitis diagnosis in HIVinfected patients, we would recommend a cryptococcal antigen assay (ideally LFA) as an initial approach. [18] Following a negative test in an adequate clinical and CSF context, empiric treatment for TBM should strongly be considered. However, it is important to consider bacteria (e.g. Streptococcus pneumoniae, Neisseria meningitidis, Listeria mono cytogenes) and syphilitic meningitis in the differential diagnosis of meningitis in HIV-infected patients. More-rare aetiologies include other fungal pathogens (i.e. Histoplasma capsulatum, Candida, Cocci dioides) and viruses (i.e. herpes virus, enterovirus). [19, 20] This study has limitations. We did not have CSF opening pressure available for the whole population. We included only culture-proven cases and not culture-negative cases, tested with techniques such as NAAT. Therefore, we did not compare clinical and laboratory differences between culture-positive and culture-negative cases. However, we did include a reasonable number of cases, all of which were culture proven, allowing rigorous case definition.
In conclusion, although some clinical and basic CSF characteristics appear useful in the differential diagnosis of TBM and CM in HIVinfected patients, an accurate algorithm was not identified. In this scenario, optimised access to more rapid, sensitive and specific laboratory tests is essential. 
